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Abstract: Although coordination compounds with phosphinonitrile ligands are already well 
known, in the vast majority of these complexes these ligands coordinate as simple P-donors 
with their cyano groups acting as auxiliary substituents.  This led us to synthesize and study 
a series of Cu(I) complexes with two isomeric phosphinonitrile donors, namely 
2-(diphenylphosphino)benzonitrile (Lo) and 2-(diphenylphosphino)benzonitrile (Lp), 
with different ligand-to-metal ratios and possibly characterize further coordination modes 




This work describes the preparation of phosphinonitrile complexes from 
the aforementioned ligands and simple copper(I) halides  (CuX, X = Cl, Br, I), pseudohalides 
(X = CN) and from [Cu(MeCN)4][BF4]. The products were characterized by nuclear magnetic 
resonance, infrared spectroscopy and elemental analysis, mass spectrometry, and their 
solid-state structures were determined by single-crystal X-ray crystallography.           
 
In addition, luminescent properties of the Cu(I) complexes were studied and catalytic 
activity of selected complexes was tested in copper-catalyzed alkyne-azide cycloaddition 
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Autor: Bc. Filip Horký 
Katedra: Katedra anorganické chemie 
Vedoucí bakalářské práce: prof. RNDr. Petr Štěpnička, Ph.D. 
Abstrakt: Ačkoli byly koordinační sloučeniny obsahující fosfinonitrilové donory již hojně 
studovány, ve většině připravených komplexů byly tyto ligandy k centrálnímu kovu vázány 
pouze jako čisté P-donory, tj. s nekoordinovanými nitrilovými skupinami. To nás vedlo 
k přípravě a studiu komplexních sloučenin obsahující dva isomerní ligandy, 
2-(difenylfosfino)benzonitril (Lo) a 4-(difenylfosfino)benzonitril (LP), při různém poměru 




Předkládaná práce představuje nové měďné komplexy získané reakcemi zmíněných 
ligandů z jednoduchých halogenidů (CuX, X = Cl, Br, I) a pseudohalogenidů (X = CN) 
měďných a komplexy iontového typu připravené z prekurzoru [Cu(MeCN)4][BF4]. Výsledné 
komplexní sloučeniny byly charakterizovány elementární analýzou, infračervenou 
spektroskopií, hmotnostní spektrometrií, nukleární magnetickou rezonancí a jejich struktury 
byly určeny rentgenostrukturní analýzou. 
Kromě uvedeného byly studovány i luminiscenční vlastnosti získaných sloučenin 
a pro vybrané komplexy byla testována jejich katalytická aktivita v mědí katalyzované 
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In 1990, D. Seebach predicted that "the discovery of truly new reactions is likely to be limited 
to the realm of transition-metal organic chemistry, which will almost certainly provide us 
with additional »miracle reagents« in the years to come".1,2 Indeed, no other area of classic 
synthetic chemistry today offers such innovative possibilities as metal-catalyzed organic 
transformations. Transition metal-mediated reactions are becoming increasingly more 
significant not only in the synthesis of complex molecules, but also for structurally simpler, 
industrially important intermediates.3 
 
In spite of the numerous reports concerning new coordination compounds 
with nowadays popular or even uncommon transition metals and their catalytic properties, 
copper, one of the oldest transition metals to be used in synthetic organic chemistry, is again 
attracting the attention of researches worldwide – not only as a cheaper alternative 
to the generally preferred palladium, but also as an exclusive catalyst for new type 
of reactions.4 
 
In 2001 Sharpless5 introduced the concept of “click chemistry” as a type of reaction 
which is modular, wide in scope, gives very high product yields, generates only inoffensive 
byproducts that can be removed by nonchromatographic methods, and stereospecific (but not 
necessarily enantioselective). The required process characteristics include simple reaction 
conditions (ideally, the reaction should be insensitive to oxygen and water), readily available 
starting materials and reagents, the use of no solvent or a solvent that is benign 
(such as water) or easily removed, and simple product isolation. Purification (if required) 
must be possible by nonchromatographic methods (e. g., by crystallization or distillation), 
and the product must be stable under physiological conditions. Since then, click chemistry has 
become one of the most common and reliable methods to link molecules covalently, and is 
finding applications in a variety of disciplines including the chemistry of nanomaterials, 
chemical biology, drug delivery, and medicinal chemistry.6  
 
A typical example of click-type reaction is copper-catalyzed alkyne-azide 
cycloaddition (CuAAC). The 1,3-dipolar cycloaddition of azides with  alkynes was firstly 
reported by Hüisgen in 1963.7 However, it did not attract much interest until it was 
demonstrated that this slow, high temperature and unselective process leading to an equimolar 
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mixture 1,4- and 1,5-disubstitued 1,2,3-triazole regioisomers, could also be carried out under 
mild condition using Cu(I) compounds as the catalysts.6,8 In addition, a dramatic improvement 
of the regioselectivity is observed, with the 1,4-disubstituted isomer being the only product 




Scheme 1.1:   Uncatalyzed (top) and Cu-catalyzed (bottom) synthesis of 1,2,3-triazoles. 
 
Although the final heterocycle does not occur naturally, synthetic molecules 
containing the 1,2,3-triazole core show interesting chemical and biological properties.10 
1,2,3-Triazoles are stable to acid and base hydrolysis as well as under reductive and oxidative 
conditions, which turn suggests their high aromatic stabilization. At the same time, these 
heterocycles have a high dipole moment (about 5 D)11 and might be also able to participate 
actively in hydrogen binds as well as in dipolar and π···π stacking interactions. Finally, 
this moiety is relatively resistant to metabolic degradation.12,13   As a result, the CuAAC 
leading to 1,2,3-triazoles derivates has found valuable applications in drug discovery, 
dendrimer14 and polymer chemistry,15  and also in material science.16 
 
There are two main approaches that can be used to prepare a homogenous catalytic 
system for CuAAC depending on the nature of the catalyst precursor. The most widely used 
method is in situ generation of a Cu(I) species by reduction of CuSO4 ·5H2O with sodium 
ascorbate, typically in a water/alcohol mixture. The major advantage of thus obtained 
catalysts is compatibility with both oxygen and water. On the other hand, this method is not 
suitable for substrates sensitive to oxidation and may result in lowered yields associated 
with Cu(I)-mediated formation of reactive oxygen species.17,13 For the stabilization 
of generated Cu(I) oxidative state and acceleration of this reaction were used various auxiliary 





Scheme 1.2: Ligands used in CuAAC reactions: tris(benzyltriazolylmethyl)amine (TBTA),18 
disodium 4,7-diphenyl-1,10-phenanthroline-4',4''-disulfonate (BPDS),19 and 4-{[6-(azido-
methyl)-3-pyridinyl]amino-4-oxo}butanoic acid (Wu’s azide).20 
 
A different approach makes use of pre-formed Cu(I) complexes as the pre-catalyst. 
The use of defined catalytic precursors not only avoids the need for an excess 
of ligand/additives to be present, simplifying the product purification, but also allows a better 
control over the stereoelectronic properties of the Cu(I) species in the reaction media. Despite 
this, the simplicity and effectiveness of the Cu(II)/ascorbate prototocol on the one  hand, 
and problems associated with the preparation and handling of air-sensitive Cu(I) compounds 
on the other hand, have limited applications of defined Cu(I) compounds in CuAAC.17 
However, the number of reports regarding the applications of various Cu(I) pre-catalysts 




Schema 1.3: Example of compounds used as ligands in defined Cu(I) complexes utilized 





The design of a versatile catalyst that can be utilized in cycloaddition of azides 
to alkynes, no matter their substituents, as well as the improvement of reaction conditions 
in such a way that copper removal becomes completely effective (eliminating product 
poisoning) constitutes nowadays some of the challenges that will be probably overcome 
in the forthcoming years. 
 
However, applications of copper compounds are not limited to CuAAC. Although 
cross-coupling has almost become synonymous with palladium, copper-mediated reactions 
were the first of this kind to be reported.24 For instance, Ullmann reaction, described already 
in 1901, is a coupling reaction between two aryl halides producing biaryls.24 Nowadays, 
the Ullmann-type reactions include nucleophilic aromatic substitutions with various 
nucleophiles on aryl halides (Scheme 1.4). These reactions, until recently limited 
in applications by low yields, scope and the lack of selectivity, are enjoying renewed interest 
in both academic and industrial laboratories thanks to the use of reactive metal precursors 




Scheme 1.4: Copper-catalyzed Ullmann reaction (top) and Ullmann-type reactions mediated 








Scheme 1.6: Examples of Cu(I)complexes used in Ullmann-type reactions.26 
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Although only little is known about chemical properties and dynamic behavior 
of these complexes in solution partly because of possible changes in the coordination number 
and lability of the Cu(I) center,27 there are several possible mechanistic pathways leading 
to Ar-Nu products during Ullmann reactions. The most widely accepted mechanism involves 
oxidative addition of the halide to CuI(nucleophile) complex, leading to the formation 
of a CuIII intermediate (Scheme 1.7a). An alternative explanation (especially for electron-rich 
ligands) involves single-electron transfer (SET) resulting in the formation of a radical pair 
(Scheme 1.7b), which can be directly converted into the product or can form a CuIII 
intermediate after another SET step (Scheme 1.7c). Other possibility, anticipated for electron-
poor ligands, includes atom transfer mechanism (Scheme 1.7d), whereas a recent study has 
suggested that a four-centered  σ-bond metathesis mechanism could be the plausible reaction 











        




Scheme 1.7: Possible mechanisms of copper-catalyzed Ullmann-type reactions.25 
 
 In addition to their catalytic use, Cu(I) complexes have attracted attention as promising 
luminescent materials, largely due to their low cost, interesting phosphorescent properties, 
diverse structural features, and potential applications in organic light-emitting diodes, 
photosensitizers, sensing devices, biological imaging and dye-sensitized solar cells.27 A large 
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number of mono- and polynuclear Cu(I) complexes have been developed to date and 
investigated in various applications.28,29,30  
 
The recent remarkable progress in the field of Cu(I) luminescent materials has 
revealed a difference in the photophysical properties of the Cu(I) complexes and those 
of other noble metal-based luminescent materials. The most distinctive one is the thermally 
activated delayed fluorescence derived from the small energy difference between the singlet 
and triplet excited states of Cu(I) as compared to those in noble metal complexes 
with octahedral and square-planar geometries. Thus, wide modifications in the emission 
wavelength and the emission lifetime are possible for the luminescent Cu(I) complex 
systems.31   
 
Another attractive research focuses on applications of copper compounds as potential 
chemotherapeutic agents. Since the serendipitous discovery of cisplatin by Rosenberg et al. 
in 1965,32 great efforts have been focused on the anticancer properties of coordination 
compounds. The cisplatin and its successors, carboplatin and oxaliplatin, are among the most 
important chemotherapeutics in clinical use worldwide against a variety of different types of 
cancer (Scheme 1.8). Nevertheless, acquired and intrinsic drug resistance, toxicity and side 




Scheme 1.8: Traditional Pt(II) chemotherapeutics: cisplatin (a), oxaliplatin (b) 
and carboplatin (c). 
 
Hence, new strategies are being explored to overcome these complications, 
which include the development of more effective and generally less toxic drugs. In this field, 
the investigation of copper complexes started with an assumption that endogenous metals may 
be less toxic than non-essential metal such as platinum for normal cells than cancer cells. 
Copper is an essential trace element for human life, important for the function of various 
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enzymes, proteins, DNA synthesis and for regulation of intracellular redox potential. Almost 
all copper present in the serum of living organisms is bound to ceruloplasmin, the major 
copper-carrying protein in the blood. Ceruloplasmin binds both copper(I) and copper(II) ions, 
and brings them to the cell surface. Prior to its uptake into the cell, copper(II) is reduced 
to copper(I) by metalloreductases at the cell surface. Transport of copper ions through the cell 
membrane is then mediated by specific transporters.33,34,35  
 
Some copper(I) complexes mostly featuring P- and N-donors have been reported 
to show considerable cytoxic activity (Scheme 1.9). Although the mechanism of their action 
in tumor cells has not been yet clarified, the reported results suggest that copper(I) complexes 




Scheme 1.9: Examples of two phosphine-Cu(I) complexes investigated for anticancer 
activity.35 
 
The Cu(I) complexes are also known for their rich structural chemistry. The diversity 
of Cu(I) compounds can be illustrated by examining structural chemistry of cuprous halide 
complexes with ligands such as an aliphatic or aromatic nitrogen heterocycles. 
Crystallographic studies have demonstrated that complexes of CuI and a particular ligand L 
form in a variety of structures depending on the stoichiometry (Scheme 1.10). For a 1:1 CuI:L 
molar ratio, the most commonly encountered motif is the tetranuclear “heterocubane” 
structure [Cu4I4L4], in which a tetrahedron of copper atoms is embedded within a larger I4 
tetrahedron with each iodide  atom residing above a triangular face of the Cu4 tetrahedron, 
and the fourth coordination site of each copper is occupied by the additional ligand (L).37 
For CuI:L stoichiometry of 1:2, the most commonly encountered structure is an isolated 




38 Compounds of stoichiometry 1:3 have also been reported, 
being represented by [CuI(3-picoline)3], which exists as a mononuclear complex with the Cu 
and I atoms lying on a three-fold axis.39 In some cases, CuI complexes of the same 
stoichiometry (e.g., 1:1) exist in more than one stable and crystalline form. For instance, 





Scheme 1.10: Illustrations of structural diversity of Cu(I) complexes.  
 
Since it has been demonstrated that elimination of a donor from coordination sphere of 
a metal complex represents an important step in the course of catalytic processes, being 
associated with the formation of reactive intermediates with possessing an empty coordination 
site,41 hemilabile ligands are currently of considerable interest.42 These polydentate ligands 
contain at least two electronically different coordination groups (X, Y). Among these, Y 
represents a substitutionally labile group which can be displaced from the metal center but 
reactions available for re-coordination, and X is a strongly coordinating group acting as firmly 




Scheme 1.11: Hemilabile coordination of a bidentate ligand: X = substitutionally inert group, 




In many syntheses mediated by transition metals, the role of substitutionally inert 
group is represented by tertiary phosphines (PR3). Like NH3, phosphines have a lone pair 
on the central atom that can be donated to a metal. Similarly to NH3, however they are also 
π-acids, to an extent that depends on the nature of R groups in the PR3 ligand.
43 These neutral 
ligands are typical soft bases  according to the Pearson’s HSBA theory and thus form stable 
complexes with soft acids, such as  Rh(I), Ir(I), Pd(II), Cu(I), etc.44 Phosphines are versatile 
ligands whose electronic and steric properties can be altered in a systematic and predictable 
way over a very wide range by changing their substituents (Scheme 1.12). Substitution 
by groups with a low electronegativity (e.g., alkyl) strengthens σ-donor ability 
of the phosphorus atom. On the other hand, in the extreme case of PF3, π-acidity becomes 
as great as that found for CO. Introduction of bulky substituent  increases steric demands 
of a phosphine donor, which results in an increase in the angles between the substituents, 
decrease of s character of the phosphorus lone pair, and extended phosphorus-metal bond.45 
By using bulky PR3 ligands, one can favor the formation of low-coordinated metal complexes 
or can create space for small but weakly binding ligands, which would be excluded by direct 
competition with smaller ligands such as CO. The usual maximum number of phosphines that 
can bind to a single metal is two for PCy3 or P(i-Pr)3, three or four for PPh3, four for PMe2Ph, 





Scheme 1.12: Steric and electronic effect. 
 
The electronic effect of various phosphine ligands can be quantified as suggested 
Tolman, who compared the v(CO) frequencies of a series of complexes of the type 
[(PR3)Ni(CO)3], containing different PR3 ligands. Stronger phosphine donors increase 
the electron density at Ni, which is then relayed further to the CO by back donation. This, 
in turn, lowers the v(CO) frequencies. Tolman has also quantified the steric effects 
of phosphines with the so-called cone angle. This is obtained by taking a space-filling model 
of the M(PR3) group, folding back the R substituents as far as they will go, and measuring 
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the angle of the cone that will contain all of the ligand, when the apex of the cone coincides 
with the metal (Scheme 1.13).45  
 
 
     
             
           θ  




Scheme 1.13: Tolman cone angle θ. 
 
Typical examples of hybrid phosphine ligands are ether-phosphines, 
phosphine-carbonyls and amine-phosphine ligands.46  In general, the percentage 
of nitrogen-modified phosphorus ligands studied47 that exhibit hemilability is not large when 
compared with the analogous phosphorus-oxygen donors. Interesting class of potentially 
hemilabile bidentate ligands are also phosphine-nitrile donors. Even though both functional 
groups (phosphinyl and nitrile) are considered soft donor groups, dative bonding formed 
by nitrile is usually quite weak. Nitrile group (CN), which is isoelectronic with dinitrogen 
and carbon monoxide, exerts weak σ-donor and π-acceptor ability and can be readily 
displaced to afford novel coordination and organometallic complexes.48 Nitriles can interact 
with metal centers in several different ways:  (a) via simple terminal end-on coordination 
(η1-NCR), (b) as side-bonded π-donors (η2-NCR), and (c) in bridging σ,π-coordination 
(μ-η1,η2-NCR) (Scheme 14). Type (a) is the most common binding mode for nitrile donors, 




Scheme 1.14: Coordination modes of nitriles: (a) η1-NCR, (b) η2-NCR and (c) μ-η1,η2-NCR. 
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Although η1-coordination is often accompanied by an increase in the v(CN) frequency, 
in several transition metals the value of v(CN) has been found unchanged or even lower 
than for the respective free ligands. This has been ascribed to significant “back bonding” 
between the metal d orbitals and π* orbitals of the nitrile groups in these compounds.48 
 




51, these ligands coordinate 
as simple P-donors, with their cyano groups acting as auxiliary substituents. Compounds 
in which both functional groups are coordinated to a metal centre remain extremely rare 
and have not been unequivocally confirmed, by using methods of direct structural analysis 
until recently (see below).52  
 
In 1972, coordination compounds with 2-(diphenylphosphino)benzonitrile (Lo) 
of the type [M(CO)3(Lo)X]y, where M is group VII metal, were prepared and studied. 
Their infrared spectra were consistent with coordination of both the phosphorus atom 








The same ligand, 2-(diphenylphosphino)benzonitrile (Lo), was also used to prepare a trimeric 




Scheme 1.16: Trimeric complex [PtCl2(Lo)]3. 
 
Recently, our research group published a series of Au(I), Ag(I) and Cu(I) complexes 









For the first case, it was unequivocally demonstrated that phosphinonitrile donors can 
coordinate as P,N-bridges through  both soft donor sites.  The preparation and study of new 
phosphinonitrile complexes are the main aims of this work. 
 
1.1 Aims of the Thesis 
 
The aim of this Thesis was to  prepare and study copper(I) complexes containing two isomeric 
phosphinonitrile donors, namely 2-(diphenylphosphino)benzonitrile (Lo) and 4-(diphenyl-
phosphino)benzonitrile (Lp). Main emphasis was put on finding new structural motifs and 
differences in coordination behavior of these hybrid ligands. As a Cu(I) source, all commonly 
accessible  copper(I) compounds such as halides CuX (X = Cl, Br, I), pseudohalides (X = CN, 
SCN), and ionic precursors such as  tetrakis(acetonitril)copper(I) tetrafluoroborate, 
[Cu(MeCN)4][BF4], were used. 
 
All prepared compounds were characterized by nuclear magnetic resonance 
and infrared spectroscopy, by elemental analysis, mass spectrometry, and their solid-state 
structures were determined by single-crystal X-ray diffraction analysis. In addition, 
luminescent properties of the isolated Cu(I) complexes were studied and catalytic activity of 
the selected representatives was studied in copper-catalyzed alkyne-azide cycloaddition 
(CuAAC) leading to 1,2,3-triazoles. 
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2. Results and discussion 
 
2.1 Phosphinonitrile donors 
 
Phosphinonitrile Cu(I) complexes reported in this Thesis contain two known isomeric ligands, 
viz. 2-(diphenylphosphino)benzonitrile (Lo)57,54,58 and 4-(diphenylphosphino)benzonitrile 
(Lp),57,59,60 which can both be regarded functional derivatives of the ubiquitous 
triphenylphosphine (Scheme 2.1). Different spatial distribution of the donor groups in Lo 
and Lp obviously leads to different coordination behavior. Thus, ligand Lp can be expected to 
coordinate metal ions only via the phosphine group (Lp-κP) or form bridges (μ(P,N)-Lp) 
between two metal atoms. In contrast, the mutual orientation of nitrile and phosphine groups 
in Lo can allow for chelate coordination to one metal atom (Lo-κ2P,N), although the nature 
of the nitrile group, mostly its rod-like geometry and rigidity, disfavors this coordination 
mode.     
  
 
     




Scheme 2.2: Synthesis of phosphinonitrile ligands Lo and Lp. 
 
Ligands Lo and  Lp donors were prepared by using organolithium reagents according 
to the literature (Scheme 2.2).58,60 Lp is described in the literature as a pale yellow solid.60 We 
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obtained a product which showed an intense yellow luminescence caused by an unidentified 
trace impurity, which could not be removed by chromatography. Fortunately, the impurity 
could be removed by addition of charcoal to a solution of Lp in hot heptane. Subsequent 
filtration and crystallization by cooling afforded analytically pure Lp as a white 
microcrystalline product.  
 
The structure of Lo had been determined before.61 However, to the best of our 
knowledge, the structure of Lp has not yet been published. We obtained a single-crystal 
of this compound suitable for X-ray analysis by slow cooling of its solution in hot heptane 




Figure 2.1: Molecular structure of ligand Lp. Displacement ellipsoids are shown at the 50% 
probability level.  
 
Ligand Lo crystallizes61 with the symmetry of the triclinic space group P1̅ and two 
formula units per the unit cell. On the other hand, ligand Lp crystallizes with the symmetry of 
the monoclinic space group P21/n and four formula units in the unit cell. Selected structural 
parameters for both ligands are shown in Table 2.1. Crystallographic data are presented 








Table 2.1: Selected geometric data for phosphinonitrile ligands Lp and Lo (in Å and ˚).61 
 
 Parametr Lp Lo 
 
 Parametr Lp Lo 
N-C7 1.148(2) 1.141(1) 
 
C1-C7-N 178.7(2) 179.0(2) 
P-C14 1.839(2) 1.833(2) 
 
C4-P-C8 101.4(1) 103.5(1) 
P-C8 1.834(2) 1.830(2) 
 
C8-P-C14 103.8(1) 103.5(2) 
P-C4 1.834(2) 1.838(2) 
 
C4-P-C14 102.7(1) 101.0(1) 
      
 
C6-C1-C7 119.2(2) 119.7(2) 
    
C2-C1-C7 120.7(2) 118.5(2) 
    
P-C4-C5 119.6(1) 117.7(2) 
    
P-C4-C3 121.6(2) 124.9(2) 
 
2.2 Synthesis of Cu(I) complexes 
 
Several copper(I) compounds were utilized  as a source of the Cu(I) ions. Namely, copper(I) 
halides CuX (X = Cl, Br, I), selected  pseudohalides (X = CN, SCN) 
and tetrakis(acetonitrile)copper(I) tetrafluoroborate. All complexation reactions were 
performed at the 1:1 and 1:2 metal-to-ligand ratios. 
  
The preparation of the complexes was typically accomplished by simple mixing 
of the respective ligand with the selected Cu(I) precursor at the given stoichiometry ratio 
in a polar solvent (CH2Cl2, MeOH or their mixture). After stirring (typically for 2 h), 
the solvent was evaporated, the solid residue was dissolved in a small amount of a suitable 
solvent, and the resulting solution was filtered and layered by a non-polar solvent to induce 
crystallization. 
 
Complexes containing Lo 
 
All six Cu-halide complexes containing Lo donor, compound 1, 2, 3, and 4a-c, were 
successfully crystallized and structurally characterized (Table 2.2). In their structures, four 
different coordination modes were detected. The reaction of CuCl with Lo at the 1:1 molar 
ratio surprisingly yielded a product with Cu:Lo composition of 4:3, complex 1. On the other 
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hand, crystallization of the solid obtained by the reaction of CuI and Lo at the same ratio led 
to a product with 3:2 stoichiometry (Cu:Lo), complex  3. The Cu:Lo molar ratios in other 
halide complexes (compounds 2 and 4a-c) corresponded with the reaction stoichiometry 
(Scheme 2.3). 
 
Reaction of copper(I) cyanide and Lo at both tested ratios (i.e., at 1:1 and 1:2 CuCN:Lo 
ratios) produced the same crystalline product with 1:1  metal-to-ligand stoichiometry 
(Scheme 2.3, compound 7). Direct reaction of copper(I) thiocyanate with Lo led to a white 
precipitate, which proved to be insoluble in all common solvents (CH2Cl2, MeOH, EtOH, 
MeCN,...). It was thus impossible to prepare a defined crystalline product (even by reactive 
diffusion approach), and the product of this reaction could not be adequately characterized. 
 









CuCl + Lo 1:1 [Cu4Cl4(Lo)3] 1 
CuCl + Lo 1:2 [CuCl(Lo)2] 4a 
CuBr·SMe2 + Lo 1:1 [Cu4Br4(Lo)4] 2 
CuBr·SMe2 + Lo 1:2 [CuBr(Lo)2] 4b 
CuI + Lo 1:1 [CuI(Lo)·CuI·CuI(Lo)·2CHCl3]n 3 
CuI + Lo 1:2 [CuI(Lo)2] 4c 
CuCN + Lo 1:1 [CuCN(Lo)] n 7 
CuCN + Lo 1:2 [CuCN(Lo)]n 7 
CuSCN + Lo 1:1 unknown insoluble product - 
CuSCN + Lo 1:2 unknown insoluble product - 
[Cu(MeCN)4][BF4] + Lo 1:1 [Cu2(MeCN)2(H2O)2(Lo)2][BF4]2 8 
[Cu(MeCN)4][BF4]  + Lo 1:2 
[Cu3(Lo)6][BF4]3·CH2Cl2 
[Cu(Lo)(LoOMe)]2[BF4]2·6CHCl3 
9               
10 
 
Reactions of tetrakis(acetonitrile)copper(I) tetrafluoroborate with Lo led to three quite 
unexpected products (Table 2.2). The reaction performed at the ratio of 1:1 afforded 
a dinuclear product which contained μ(P,N)-bridging Lo, acetonitrile and water as the ligands 
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(Scheme 2.3, compound 8). The product of the reaction performed at the Cu:Lo ratio 1:2 
furnished a mixture of trimeric complex [Cu3(Lo)6][BF4]3 and another product, in which one 
of the nitrile groups reacted with the methanol used as solvent to form a phosphino-imidate 
ligand (Scheme 2.3, compounds 9 and 10). Experiments aimed at the preparation of 
a complex featuring two ligands with imidate groups failed (lengthening of the reaction time, 
refluxing of the complex in methanol). Although unable to isolate this complex, we observed 
peaks corresponding to [Cu(LoOMe)2]





Scheme 2.3: Schematic depiction of the structures of complexes containing Lo. The arrows 
indicate the propagation of the polymeric chains. 
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Complexes containing Lp 
 
Experiments with ligand Lp proved to be significantly less fruitful (Table 2.3). For instance, 
the reactions of copper(I) chloride and copper(I) bromide  at the 1:1 molar ratio resulted 
in polymeric complexes 5 (Scheme 2.4). On the other hand, copper(I) iodide, and 
in a negligible extent also copper(I) bromide, furnished heterocubanes 6 (Scheme 2.4). 
Analogous reactions at the 1:2 molar ratio gave solid products which defied all attempts 
of crystallization, separating as oily intractable materials. Hence, these compounds were not 
studied further.  
 









CuCl + Lp 1:1 [CuCl(Lp)·2CHCl3]n 5a 
CuCl + Lp 1:2 non-crystalline material - 





CuBr·SMe2 + Lp 1:2 non-crystalline material - 
CuI + Lp 1:1 [CuI(Lp)]4 6c 
CuI + Lp 1:2 non-crystalline material - 
CuCN + Lp 1:1 unknown insoluble product - 
CuCN + Lp 1:2 unknown insoluble product - 
CuSCN + Lp 1:1 unknown insoluble product - 
CuSCN + Lp 1:2 unknown insoluble product - 
[Cu(MeCN)4][BF4] + Lp 1:1 unknown insoluble product - 
[Cu(MeCN)4][BF4] + Lp 1:2 unknown insoluble product - 
 
In the case of reactions with pseudohalides, the products were obtained in the form 
of insoluble precipitates. This is probably due to a poor solubility of Cu(I) pseudohalides 
themselves, or a possible formation of coordination  polymers. Insoluble products resulted 
also from the reactions of Lp with tetrakis(acetonitrile)copper(I) tetrafluoroborate (at both 




In addition, the reactions of tetrakis(acetonitrile)copper(I) tetrafluoroborate with both 
ligands  Lo and Lp (ratio 1:1) were studied. During these studies it was found that irrespective 
of the order of the addition of the ligands, an insoluble product is formed once ligand Lp is 




Scheme 2.4: Schematic depiction of the structures of complexes containing Lp. The arrows 
indicate propagation of polymeric chain. 
 
 
2.3 X-ray diffraction analysis 
 
The crystal structures of compounds 1-10 were determined by single-crystal X-ray diffraction 
analysis. Selected crystallographic data for all complexes are presented in Attachments. 
 
The structure of [(μ-Cl)3(μ3-Cl)Cu4(Lo-κP){μ(P,N)-Lo}2] (1) 
 
Colorless crystals of complex 1 were grown by liquid-phase diffusion of hexane 
into a solution of this complex in methanol/dichloromethane (1:1). The compound crystallizes 
in triclinic crystal system with the symmetry of the 𝑃1̅ space group and two formula units per 






Figure 2.2:  Molecular structure of 1. Displacement ellipsoids correspond to the 50% 
probability level. All hydrogen atoms are omitted for clarity.  
 
X-ray analysis of 1 reveals a tetranuclear structure with two tetrahedrally (Cu1 
and Cu4) and two trigonally (Cu2 and Cu3) coordinated copper(I) atoms, which are all non-
equivalent (Scheme 2.5). Both tetrahedrally coordinated copper atoms are surrounded by two 
chloride ions, one phosphine and one nitrile group. The Cu2 atom binds phosphine group and 
two chloride ions, whereas the Cu3 atom coordinates only three chloride ions with an average 
Cu-Cl distance of 2.28 Å. The distance of Cu3 to Cl2 of 2.940(1) Å suggests a possible 
weaker supporting interaction and can lead to tetrahedral geometry around Cu3. The complex 
contains two ligands Lo, whose both functional groups are coordinated, and one Lo ligand that 
binds as a simple P-donor, with its nitrile group acting as an auxiliary substituent. Selected 
interatomic distances and angles are presented in Table 2.4. A similar type of structure was 








Table 2.4: Selected data for complex 1 (in Å and ˚).  






























    
 
Cl3-Cu3-Cl4 116.9(1) 
    
  
 The structure of [(μ-Br)2(μ3-Br)2Cu4(Lo-κP)2{μ(P,N)-Lo}2] (2) 
 
Yellow crystals of 2 suitable for X-ray diffraction analysis were grown by liquid-phase 
diffusion of hexane into a solution of 2 in 1,2-dichloroethane. The compound crystallizes 
in triclinic crystal system with the symmetry of the 𝑃1̅ space group and one formula unit 




Figure 2.3:  Molecular structure of 2. Displacement ellipsoids are scaled to the 50% 




The structure of 2 can be described as a tetranuclear ,,open heterocubane”. Of the four 
Lo ligands, two employ both functional groups in coordination and two coordinate 
as P-monodentate donors.  All copper atoms are tetrahedrally coordinated while the bromide 




Scheme 2.6: The structure of 2. 
 
Among the form Cu2Br2 squares, the longest Cu-Br bond is associated with Cu1a and 
Br2a (2.602(1) Å), and the shortest one  with atoms Cu1a and Br1a (2.486(1) Å). The smallest 
angle in the squares represents the Cu2a-Br2a-Cu1 angle (74.08(1)˚), and the most opened is 
the Br2a-Cu1a-Br1 angle (103.8(1)˚). Selected interatomic distances and angles are presented 
in Table 2.5 and correspond with an analogous complex containing triphenylphosphine.63 
 
Table 2.5: Selected data for complex 2 (in Å and ˚).  
    
 























    
The structure of [(μ3-I)Cu(μ2-I)2Cu2{μ(P,N)-Lo}2]n (3) 
 
Yellow-white crystals of 3 used for X-ray diffraction analysis experiment were 
obtained by liquid-phase diffusion of hexane into a solution of 3 in chloroform. The 
32 
 
compound crystallizes as a stoichiometric solvate 3·2CHCl3 in the monoclinic crystal system 
with the symmetry of the C2/c space group and four formula units for the unit cell. Molecular 
structure of this coordination polymer is shown in Figure 4. Selected interatomic distances 








Figure 2.4:  Structure of polymer 3. Arrows symbolize the direction of other bonds. 
Displacement ellipsoids are shown at the 50% probability level. For clarity, all hydrogen 
atoms are omitted. 
 
The structure of 3 reveals polymeric complex comprising trigonally (Cu2) 
and tetrahedrally (Cu1) coordinated copper atoms (Scheme 2.7).  Distorted trigonal I3 
environment around the copper Cu2 ion contains two equivalent and one unique Cu-I bonds 
(2.762(1) Å, 2.567(1) Å).  Each of the tetrahedrally copper ions are coordinated by two iodide 
ions and two Lo ligands (one through the phosphorus and one through its CN group) 
which interconnect the trimeric Cu3I3 units into an infinite one-dimensional chain. The iodide 
ions bind as μ-I or μ3-I bridges. The smallest angle in the Cu2I2 square represents the Cu1-I2-
Cu2 angle (60.4(1)˚) and the most opened is the Cu1-I2-Cu2 angle (111.6(1)˚). Two 
structurally equivalent squares are mutually tilted as evidenced by the I1a-Cu2-I1b angle 
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of 112.0(1)˚. Additional interatomic distances and angles are presented in Table 2.6. Similar 
structure motive was observed in the molecular complex featuring 2,5-bis[(diphenyl-
phosphino)-methyl]thiophene.64 
 
Table 2.6: Selected data for complex 3 (in Å and ˚).  
    
 




















   
     
The structures of [CuX(Lo-κP)2] (4a-c) 
 
Colorless crystals of 4a were grown by liquid-phase diffusion of hexane into a solution 
of this complex in ethyl acetate. The compound crystallizes in monoclinic crystal system 
with the symmetry of the C2/c space group and four units per the unit cell. The compound 4a 
as seen in this crystal structure is depicted in Figure 2.5. Colorless crystals of 4b suitable 
for X-ray diffraction analysis were obtained similarly. However, the compound crystallizes 
in triclinic crystal system with the symmetry of the 𝑃1̅ space group and two units in the unit 
cell. The molecular structure of 4b is shown in Figure 2.6. Finally, colorless crystals of 4c 
used for X-ray diffraction analysis experiment were obtained by liquid-phase diffusion 
of hexane into a solution of 4c in chloroform. The compound crystallizes in monoclinic 
crystal system with the symmetry of the C2/c space group and four units per the unit cell. 
Molecular structure of this complex molecule is shown in Figure 2.7. 
 
Compounds 4a-c can be described as mononuclear complexes with trigonally 
coordinated metal centers. The copper(I) atoms have similar distorted XP2 coordination 
environments and the phosphinonitrile ligands coordinate only as P-monodentate donors. 
In the case of 4a and 4c, both Lo ligands are symmetrically equivalent. The Cu-P bond lengths 
in these complexes are very similar, differing only at the second decimal place (average value 
2.242 Å). However, a substantial variation is observed for the P-Cu-P angles (142.2(1)˚ 
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for 4a, 123.9(1)˚ for 4b, and 123.2(1)˚ for 4c). Selected interatomic distances and angles are 




Figure 2.5:  Molecular structure of 4a. Displacement ellipsoids are shown at the 50% 




Figure 2.6:  Molecular structure of 4b. Displacement ellipsoids are scaled to the 50% 
probability level. Hydrogen atoms are omitted. 
 
 
Figure 2.7:  Molecular structure of 4c. Displacement ellipsoids enclose at the 50% probability 
level. The hydrogen atoms are not shown. 
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Table 2.7: Selected geometric data for complexes 4a-c (in Å and ˚).  
  
     
  
     4a 4b 4c 
  
  4a 4b 4c 
Cu-P1 2.238(1) 2.253(1) 2.244(1) 
  
P1-Cu-P2 142.2(1) 123.9(1) 123.2(1) 
Cu-P2 - 2.234(1) - 
  
P1-Cu-X 108.9(1) 111.0(1) 118.5(1) 
Cu-X 2.251(1) 2.334(1) 2.490(1) 
  
P2-Cu-X - 124.9(1) - 
N1-C7 1.141(1) 1.141(3) 1.142(3) 
  
C1-C7-N1 177.6(1) 178.6(2) 177.9(2) 
N2-C2 - 1.142(3) - 
  
C1-C7-N2 - 177.8(2) - 
P-C14 1.823(2) 1.827(2) 1.1824(2) 
      P-C14 1.826(2) 1.8212(2) 1.822(2) 
      P-C4 1.837(2) 1.832(2) 1.836(2) 
      
 
The structures of [{μ(P,N)-Lo}Cu(μ2-X)]n (5a and 5b) 
 
Yellow crystals of complex 5a were grown by liquid-phase diffusion of hexane into a solution 
of this complex in chloroform. The compound crystallizes as solvate 5a·2CHCl3 
in monoclinic crystal system with the symmetry of the P21/n space group. The molecular 
structure of 5a is shown in Figure 2.8. Yellow crystals of 5b used for X-ray diffraction 
analysis experiment were obtained by liquid-phase diffusion of hexane into a solution of 5b 
in dichloromethane. The compound crystallizes as solvate 5b·0.5CH2Cl2 in triclinic crystal 
system with the symmetry of the space group P1̅. The complex molecule in the structure 
of 5b·0.5CH2Cl2 is disordered. The Cu2Br2 units occupy two positions. The structure depicted 
in Figure 2.9 shows the major contributing moiety (occupancy 94.8(1)%). 
 
Table 2.8: Selected data for complex 5a (in Å and ˚). 
 
    
  









































Figure 2.8: Molecular structure of 5a. Displacement ellipsoids are shown at the 50% 
probability level. The arrows indicate propagation of the polymeric chain. Hydrogen atoms 
are not shown. 
 




















    
P1b-Cu1-Br1c 111.4(1) 
    
P1-Cu1-Br1c 109.8(1) 
 
Each copper(I) ion in the structure of 7 and 8 is coordinated by two Lp ligands (one 
through the phosphorus and one through its CN group), and the resulting Cu(Lp)2 units are 
connected into dimeric moieties by a pair of asymmetric halide bridges [Δ(Cu-X) ≈ 0.04 Å] 
that complete the distorted tetrahedral coordination spheres around the Cu(I) ions. Because 
each ligand acts as P,N bridge between two adjacent dicopper(I) units, the dimer units are 
interlinked into infinite chains.  Similar types of these polymeric complexes were prepared 
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by the reaction of copper(I) halides with 1’-(diphenylphosphino)-1-cyanoferrocene.52 Selected 





Figure 2.9:  Molecular structure of 5b. Displacement ellipsoids are shown at the 50% 
probability level. The arrows indicate propagation of polymeric chain. Note: only the major 
contributing disordered Cu and Br ions are shown and all hydrogen atoms are omitted. 
 
The structures of heterocubanes [(μ3-X)4{Cu(Lo-κP)}4] (6b and 6c) 
 
Colorless crystals of 6b used for X-ray diffraction analysis experiment were obtained 
by liquid-phase diffusion of hexane into a solution of 6b in dichloromethane. The compound 
crystallizes as solvate 6b·CH2Cl2 in orthorhombic crystal system with the symmetry 
of the C2221 space group and four units per the unit cell. The structure of 6b in this crystal 
structure is depicted in Figure 2.10. Colorless crystals of 6c for X-ray diffraction analysis 
experiment were grown similarly. This compound crystallizes in tetragonal crystal system 
with the symmetry of the I41/a space group and four units per the unit cell. The molecular 
structure of 6c is shown in Figure 2.11. 
 
         Molecular structures of 5a and 5b adopt typical heterocubane structures, in which each 
copper(I) atom has a distorted X3P tetrahedral coordination environment. All phosphinonitrile 
ligands coordinate exclusively as P-monodentate donors. The interatomic distances within 
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the Cu4X4 cube in 5a and 5b are within the range observed for analogous [CuX(PPh3)]4 
complexes.68 The faces of the heterocubane moiety are distorted from the ideal square shape. 
The interface Cu···Cu contacts are always shorter than the X···X distances. This is especially 
true for 6c, showing Cu···Cu separations of 2.931(1) Å and I···I distance of 4.344(1) Å. 
Selected interatomic distances and angles are presented in Tables 2.10 and 2.11. The structure 




Figure 2.10:  Molecular structure of 6b. Displacement ellipsoids are shown at the 50% 
probability level. The hydrogen atoms are not shown. 
        Table 2.10: Selected data for complexes 6c (in Å and ˚). 
 
    
 






































































































Figure 2.11:  Molecular structure of 6c. Displacement ellipsoids are shown at the 50% 




The structure of [{μ(C,N)-MeCN}Cu(Lo-κP)]n (7) 
 
Colorless crystals of 7 suitable for single-crystal X-ray diffraction analysis resulted by liquid-
phase diffusion of hexane into the solution of 7 in dichloromethane. The compound 
crystallizes in monoclinic crystal system with the symmetry of the P21/c space group. 





Figure 2.12:  Molecular structure of 7. Displacement ellipsoids are shown at the 50% 
probability level. The arrows indicate propagation of polymeric chain. For clarity, all 
hydrogen atoms are omitted. 
 
Table 2.12: Selected data for complex 7 (in Å and ˚). 
 
    
 
































Compound 7 is a one-dimensional coordination polymer, in which phosphinonitrile 
ligands coordinate as P-monodentate donors.  Thus resulting identical CuLo units are 
interlinked into an infinitive ribbon through disordered cyanide bridges that complete trigonal 
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coordination sphere around the Cu(I) ions. Selected interatomic distances and angles are 
presented in Table 2.12. Similar type of polymer complex was prepared by the reaction 
of copper(I) cyanide with tricyclohexylphosphine.69 
 
The structure of [{μ(P,N)-Lo}2{Cu(H2O)(MeCN)}2][BF4]2 (8) 
 
Colorless crystals of 8 used for X-ray diffraction analysis were obtained by liquid-phase 
diffusion of hexane into a solution of 8 in ethyl acetate. The compound crystallizes 
in monoclinic crystal system with the symmetry of the P21/c space group and two formula 




Figure 2.13:  Molecular structure of 7. Displacement ellipsoids are shown at the 50% 
probability level. The BF4








Complex 8 is a dimer, in which two Lo donors bridge equivalent Cu(MeCN)(H2O) 
units. The copper(I) centers are thus coordinated by MeCN, H2O and two ligands constituting 
irregular tetrahedrons (Scheme 2.8). Selected interatomic distances and angles are presented 
in Table 2.13.  This kind of structure is rarely seen in literature. A remotely similar structure 
was reputed for a copper(I) complex with 1-(2-(diphenylphosphino)phenyl)-4-phenyl-1H-
1,2,3-triazole.70 
 
Table 2.13: Selected data for complexes 8 (in Å and ˚). 
 
    
 











































The structure of [{μ(P,N)-Lo}2Cu]3[BF4]3 (9) 
 
Colorless crystals of 9 for X-ray diffraction analysis experiment were grown by liquid-phase 
diffusion of hexane into a solution of 9 in dichloromethane. The compound crystallizes as 
solvate 9·CH2Cl2 in monoclinic crystal system with the symmetry of the Cc space group and 









Figure 2.14:  Molecular structure of 9. Displacement ellipsoids are shown at the 50% 
probability level. The BF4
− anions and hydrogen atoms are not shown for clarity. 
 
Compound 9 is a cyclic tricopper(I) complex, in which each copper(I) ion is 
coordinated by four Lo ligands (Scheme 2.9). Although each ligand acts as a P,N-bridge, 
the structure is asymmetric and every copper(I) atom with distorted N2P2 tetrahedral 
coordination environment is structurally independent (Cu···Cu distances 7.767(1), 4.741(1), 
4.833(1) Å). Selected interatomic distances and angles are presented in Table 2.14. 
 
Table 2.14: Selected data for complexes 9 (in Å and ˚). 
           Cu1 Cu2 Cu3 
 
 Cu1 Cu2 Cu3 
Cu-N 1.992(4) 2.008(4) 1.996(4) 
 
N-Cu-N‘ 113.7(2) 112.7(2) 114.3(2) 
Cu-N‘ 2.013(4) 2.017(4) 2.010(4) 
 
N‘-Cu-P 115.0(2) 106.9(1) 115.5(2) 
Cu-P 2.282(2) 2.260(2) 2.274(2) 
 
N-Cu-P‘ 99.2(2) 112.2(2) 97.9(2) 
Cu-P‘ 2.283(2) 2.272(2) 2.275(2) 
 
N‘-Cu-P‘ 101.51(2) 104.0(2) 112.6(2) 
     







The structure of [{μ(P,N)-Lo}2{Cu(MeOLo-κP)}2][BF4]2 (10) 
 
Colorless crystals of 10 for X-ray diffraction analysis experiment were obtained by liquid-
phase diffusion of hexane into a solution of this complex in chloroform. The compound 
crystallizes as solvate 10·6CHCl3 in monoclinic crystal system with the symmetry of the C2/c 
space group and four formula units in the unit cell. The structure of compound 10 is shown 




Figure 15:  Molecular structure of 10. Displacement ellipsoids are shown at the 50% 
probability level. The counter anions and hydrogen atoms are omitted for clarity. 
 
Compound 10 is a dicopper(I) complex built up from two equivalent Cu(MeO-Lo) 
units that are connected into dimeric units through asymmetric P,N-bridges represented 
by a pair of Lo ligands completing distorted tetrahedral coordination spheres around the Cu(I) 
ions (Scheme 2.10). The Cu-P distances for both types of ligands are the same (Cu-P1 and 
Cu-P2 = 2.240(1) Å). The Cu-N distance for the nitrogen of the imidate group is slightly 
longer than for the nitrogen in the nitrile group (2.092(2) Å vs. 2.006(2) Å). Selected 
interatomic distances and angles are presented in Table 2.14. Compound 10 is the first 







Table 2.15: Selected data for complexes 10 (in Å and ˚). 









































         
 
 
Scheme 2.10: Schematic representation of the structure of 10. 
 
2.4 Infrared spectra 
 
In the present case, infrared spectroscopy is particularly suitable for following the stretching 
vibrations of the nitrile groups, which are clearly identified and do not overlap with other 
bands (Table 2.16). The v(C≡N) bands in all complexes are usually slightly shifted to higher 
energies (average shift is only about 7 cm−1) compared to the respective uncoordinated 
ligands (in the case of 6c, the nitrile band is found at exactly the same position). The shift was 
observed even when the nitrile group is not involved in coordination. Although many 
complexes contain two or more non-equivalent ligands coordinating in completely different 
modes, only one nitrile band is typically observed. Two ,,nitrile bands” were observed only 
in the case of complex 7 (due to cyanide group) and 8 (contains acetonitrile). The spectrum of 
complex 10 possessing a phosphinoimide donor, shows a band attributable to NH stretching 







Table 2.16: Positions of the v(C≡N) bands in the IR spectra.  
 
Complex Lo 1 2 3 4a 4b 4c 7 
v [cm−1] 2220 2235 2229 2226 2222 2223 2225 2128a, 2227 
                  
Complex 8 9 10 Lp 5a 5b 6c   
v [cm−1] 2278, 2308b 2236 2238 2223 2234 2230 2223   
 
av(C≡N) band of CN.71 bv(C≡N) band of MeCN.72 
 
2.5 NMR spectra 
 
The synthesized donors Lo and Lp were characterized by 1H, 13C and 31P NMR spectra which 
confirmed their purity.61 
 
NMR analysis of the complexes in solution furnished only limited information 
regarding their structures. For instance, the 1H NMR spectra showed only signals 
of the phenyl groups and were not differentiated. 31P{1H} NMR spectroscopy suggested 
fluxional nature of the prepared complexes. All measured 31P{1H} NMR signals were broad 
and, for complexes 3, 4a, 5a and 10, the 31P{1H} NMR signals were not even detected 
because of extreme broadening. In some cases (complex 9), the observation of two signals 
suggested the presence of several compounds in a solution. Notably, in all complexes with Lo 
the 31P NMR signals shifted downfield confirming coordination of the phosphorus atom. 
On the other hand, signals of complexes with Lp were surprisingly shifted upfield 
as compared with the free ligand. 
 
2.6 Mass spectra 
 
 
The most stable ion, which was detected by low-resolution electrospray ionization technique 
(ESI) for all prepared complexes (with a single exception), was fragment [Cu(L)2]
+ 
(L = Lo or Lp). Actually, in many cases this was the one and only ion observed in the ESI 
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mass spectra, which consequently provided only a little insight into the complex 
stoichiometry or their structure.  
 
The exception was the mass spectrum of cyanide complex 7 showing a fragment ion 
[Cu2CN(Lo)2]





Scheme 2.11: Possible formation of the [Cu2CN(Lo)2]
+ fragment form 7. 
 
Fragments of similar type were observed also for the polymeric complexes 5a and 5b 
([Cu2X(Lp)2]
+) and for the molecular complexes 1 and 4a ([Cu2X(Lo)2]
+). For these polymeric 
complexes, there are two probable ways of fragmentation based on the original structure 
(Scheme 2.12). It can be supposed that fragmentation (a) is more likely because of requires 




Scheme 2.12: Two possibilities of forming ion [Cu2X(Lp)2]





Quite a number of fragments was observed in the ESI spectrum of complex 10 which 
contained phosphinonitrile and phosphinoimidate donor. In additon to the expected fragments 
[Cu(MeO-Lo)(Lo)]+ and [Cu(MeO-Lo)]+, there were also observed
  fragments [Cu(Lo)2]
+ 
and [Cu(MeO-Lo)2] presumably resulting  by random redistribution in solution or during 
the ionization.  
 
In the spectra of 3 and 5b were also observed adducts with alkali metal ions, namely 
[Cu(Lp)2BrK]




Since the prepared complexes exhibit diverse structures, and are accessible from simple and 
easily synthesized ligands, we have decided to test them as defined catalysts. The majority of 
the prepared complexes are polynuclear in nature. In 2013, dinuclear copper intermediate was 
postulated in catalytic cycle pathway of copper-catalyzed alkyne-azide cycloaddition reaction 





Scheme 2.13: Plausible mechanism of copper-catalyzed alkyne-azide cycloaddition.73 
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For screening experiments, we used the coupling of commercially available benzyl azide 
(available as 0.5 M solution in dichloromethane) and phenylacetylene in presence of 
0.5 mol.% of catalyst (Scheme 2.14). The reaction was monitored after 2 h. The obtained 




Scheme 2.14: Reaction used for the initial screening experiments. 
 







1 [Cu4Cl4(Lᵒ)3]  24 
4a [CuCl(Lᵒ)2]  13 
2 [CuBr(Lᵒ)]4  17 
4b [CuBr(Lᵒ)2] 14 
3 [CuI(Lᵒ)2·CuI·CuI(Lᵒ)·2CHCl3]n 5 
4c [CuI(Lᵒ)2]  21 
7 [CuCN(Lᵒ)]n 17 
5a [CuCl(Lᵖ)]n 18 
5b [CuBr(Lᵖ)]n 9 
6c [CuI(Lᵖ)]4 6 
  CuCl 10 
 
a The results are average of two experiments. 
 
The most satisfactory yelds of 1,2,3-triazole (24%) were obtained with catalyst 1. However, 
even such a result is relatively poor upon comparing the catalytic efficacy of CuCl itself 
(10%) and, mainly, the results reported in the literature (0.1% cat, 10 min, ≈ 100% yield).17 
This lead us to abandon further reaction tests. 
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2.8 Luminescence studies 
 
Copper(I) compounds are attracting considerable attention as promising luminescent 
materials. This led us to investigate optical properties of complexes reported in this Thesis.   
 
The diffuse reflectance spectra were recorded for all defined halide complexes 
(compounds 1-6), whose purity was confirmed by elemental analysis. The spectra were 
analyzed by the Kubelka-Munk function, providing a correlation between the reflectance 
and concentration. The concentrations of an absorbing species were determined using 
the Kubelka-Munk formula:74  
F(R) = (1 – R)²/2R = k/s = Ac/s 
where R = reflectance, k = absorption coefficient, s = scattering coefficient, c = concentration 
of the absorbing species, and A = absorbance. 
The absorption spectra measured in the solid state are shown in Figures 2.16 and 2.17. 
The spectra exhibit broad bands around 260 nm, which is characteristic of an arylphosphine. 
This band can be tentatively assigned to a mixed n →  𝜋∗ and  𝜋 →  𝜋∗ transition; the former 
being the transition of an electron from the lone pair orbital on phosphorus to an empty 
antibonding orbital on the phenyl ring.75  A stung band at 350-410 nm can be attributed 
to an electronic transition involving by the copper, the halide ligands, or both.76 Positions 
of these maxima consequently correspond to the type of structure: compounds 4a-c (360, 358, 
347 nm), compounds 5b-c (383, 384 nm). 
All studied complexes are emissive (λexc = 390 nm) in the solid state at room 
temperature with emission maxima in the range from 522 to 573 nm (Figure 2.18 and 2.19, 
Table 2.17). For polynuclear complexes, a common feature is the mixing of electron states so 
that an assignment of electron state with concepts drawn from simple one-electron transitions 
may be quite misleading.30 The shifts of emission maxima are independent on the type 
of halide atoms: 526, 562, 573 nm for chloride, 522, 523, 560 nm for bromide, 506, 523, 559 
nm for iodide. The shifts of the emission maxima for mononuclear complexes 4a-c do not 
follow the trend  in ligand field splitting (I− < Br− < Cl−).77 However, the shifts  appear to be 
characteristic of the particular structure (for example ,,open squares” structures  2 and 3 emit 
51 
 
at 522 and 523 nm, while the polymeric structures 5a and 5b show emission  maxima at 562 
and 560 nm). 
Table 2.17: Absorption and emission maxima of halide complexes (λexc = 390 nm).
a 
 
Compound 1 2 3 4a 4b 4c 5a 5b 6c 
λabs 387 405 408 360 358 347 383 384 410 
λem 526 522 523 573 523 559 562 560 506 
 
a  all maxima in nm. 
 
 
Figure 2.16: Uv-vis absorption spectra of compounds 1-4b as crystals at 298 K. 
 
 





Figure 2.18: Normalized emission spectra of compounds 1-4b as crystals at 298 K 




Figure 2.19: Normalized emission spectra of compounds 4c-6c as crystals at 298 K 









The main aim of this Thesis was the investigation of coordination properties of a pair of 
isomeric phosphinonitrile donors that are poorly described in the literature. A series of new 
copper(I) complexes with these donors were successfully synthesized and fully characterized 
by nuclear magnetic resonance, infrared spectroscopy and elemental analysis, mass 
spectrometry, and their solid-state structures were determined by single-crystal X-ray 
crystallography.   
 
X-ray crystallographic analysis revealed mononuclear, polynuclear or even polymeric 
structure with unusual distorted trigonal or tetrahedral coordination environments around 
the copper(I) ions. In these complexes, the phosphinonitrile ligands act as P-monodentate or 
P,N-bridging donors. All Cu halide complexes investigated in this work are luminescent. 
Emission and absorption spectra were received in the solid state. Besides, newly prepared 
compounds were tested as catalysts in copper-catalyzed alkyne-azide cycloaddition. 









4.1 Material and methods 
 
All reactions were performed under an argon atmosphere using standart Schlenk 
techniques.78 Anhydrous dichloromethane and methanol were obtained from a PureSolv MD5 
Solvent Purification System (Innovate Technology Inc., USA). Other chemicals (Alfa-Aesar 
or Sigma Aldrich) and solvents (reagent grade from Lach-Ner, Czech Republic) were used 
without any additional purification.  
 
NMR spectra were recorded at 298 K on a Varian Unity Inova 400 spectrometer (1H, 
399.95 MHz; 13C, 100.58 MHz; and 31P, 161.90 MHz). Chemical shifts (δ/ppm) are given 
relative to internal tetramethylsilane (1H and 13C NMR) and to external 85% aqueous H3PO4 
(31P), respectively. 
 
Conventional low-resolution electrospray ionization mass spectra (ESI MS) were 
recorded with an Esquire 3000 spectrometer (Bruker). The samples were dissolved in HPLC-
grade methanol.  
 
Infrared spectra were collected on Nujol mulls using an FTIR Thermo Fisher Nicolet 
760 instrument. The range investigated was 400-4000 cm−1. 
 
The UV/Vis absorption spectra were recorded on a Varian 4000 spectrometer 
equipped with an integration sphere. The powder samples were placed at the entrance of the 
sphere and measured in the diffuse reflectance mode to minimize light scattering. 
The Kubelka-Munk function was used for the analysis of these diffuse reflectance spectra. 
The steady-state fluorescence spectra were monitored using an FLS 980 (Edinburgh 
Instruments, UK) spectrofluorimeter using a holder for powdery samples. 
 
Diffraction data were collected at 150(2) K with a Nonius Kappa CCD diffractometer 
equipped with an Apex II image plate detector and Cryostream  Cooler (Oxford Cryosystem) 
using graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). The data were processed 
and corrected for absorption by the methods included in the diffractometer software. The 
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structures were solved by direct methods (SHELX9779)  and refined by full-matrix least-
squares routines based on F2 (SHELXL9779). All geometric calculations were carried out, and 




General procedure for copper catalyzed alkyne-azide cycloaddition of benzyl 
azide and phenylacetylene to give 1-benzyl-4-phenyl-1,2,3-triazole 
 
The respective Cu(I) complex (0.5 mol.% with respect to a simple [Cu] unit), benzyl azide 
(1.00 mmol, 2 ml of 0.5 M in CH2Cl2) and phenylacetylene (1.00 mmol, 0.11 ml) were added 
to a Schlenk tube, The reaction vessel was filled with argon and sealed with a rubber septum. 
The mixture was stirred for 2 h at room temperature and then evaporated under vacuum. The 








To a solution of 2-bromobenzonitrile (10.93 g, 60.0 mmol) in Et2O (300 ml) and THF (60 ml) 
under argon was added 1.6 M n-BuLi in hexane (37.6 ml, 60.2 mmol) at −78 °C. After stirring 
for 10 min, a solution of (choro)diphenylphosphine (10.7 ml, 60.0 mmol) in THF (60 ml) was 
slowly introduced within 45 min. The resulting mixture was stirred at −78 °C for additional 3 
h, then allowed to warm up to room temperature, and stirred overnight. The red-brown 
suspension was treated with saturated NaHCO3 (90 ml) and stirred for another 10 min. The 
aqueous layer was separated and extracted with Et2O (200 ml). The combined organic layers 
were dried over MgSO4 and evaporated, leaving crude product which was purified by column 
chromatography (silica gel, Et2O/hexane, 1:3). Finally, the product was dissolved in hot 
i-PrOH (ca 20 ml) and the solution cooled to room temperature. The separated colorless 
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crystals were collected on a frit and dried under vacuum. Yield of Lo:  5.54 g (32 %), 
colorless crystals.  
 
Characterization: 1H NMR (CDCl3): δ 7.02-7.06 (m, 1 H), 7.27-7.50 (m, 12 H), 7.85 (m, 1 H).
 
13C{1H} NMR (CDCl3): δ 117.59 (d, 
1JCP = 4 Hz, 1 C, 6b), 117.91 (d, 
3JCP = 33.0 Hz, 1C, 7b), 
128.76 (s, 2 C, 4p), 128.81 (s, 1 C, 3b), 129.40 (s, CH, 4 C, 3p), 132.37 (s, CH, 1 H, 4b), 
133.39 (s, 1 C, 5b), 133.71 (d, 2JCP = 5 Hz, 1 C, 2b), 134.01 (d, 
2JCP = 20 Hz, 4 C, 2p), 134.63 
(d, 1JCP = 10 Hz, 2 C, 1p), 143.02 (d,
1JCP = 20 Hz, 1 C, 1b). 
31P{1H} NMR (CDCl3): 
δ −7.9 (s). IR (Nujol, cm−1): 2220 m, 1582 w, 1434 s, 1307 w, 1281 w, 1188 w, 1154 w, 
1127 w, 1091 w, 1070 w, 1024 w, 997 w, 918 w, 851 w, 764 s, 750 s, 742 s, 727 m, 705 m, 
694 m, 579 w, 560 w, 521 w, 504 m, 488 m, 429 w. 
 
 
13C{1H} NMR signals were assigned according to the literature.61 
 





To a solution of 4-bromobenzonitrile (5.10 g, 28.0 mmol) in THF (85 mL) and hexane 
(20 mL) was added 1.6 M n-BuLi in hexane (11.2 ml, 28.0 mmol) at −78 °C. After stirring for 
5 min, neat (chloro)diphenylphosphine (5.2 mL, 29.0 mmol) was added and the mixture was 
stirred at −78 °C for 1 hour and then at room temperature for additional 2 h. The product was 
extracted with THF (3 x 60 ml), washed with 1 M NaOH (60 ml), saturated NaCl (60 ml) and 
the combined organic layers were dried over MgSO4. The crude product obtained by 
evaporating was purified by column chromatography (silica gel, AcOEt/ Hx, 1:5), the solvent 
was evaporated and the solid dissolved in hot heptane. Charcoal was added and the mixture 
was filtered and evaporated. Yield of Lp: 3.22 g (40%), white solid. Crystal for X-ray 
diffraction analysis was obtained by slow cooling of a heptane solution down to −20 °C. 
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Characterization: 1H NMR (CDCl3): δ 7.28-7.41 (m, 12 H), 7.55-7.59 (m, 2 H). 
13C{1H} 
NMR (CDCl3): δ 111.89 (s, 1 C, 4b), 118.71 (s, 1 C, 5b), 128.84 (d, 
3JCP = 7 Hz, 4 C, 3p), 
129.47 (s, 2 C, 4p), 131.68 (d, 3JCP = 6 Hz, 2 C, 3b), 133.47 (d, 
2JCP = 19 Hz, 2 C, 2b), 134.01 
(d, 2JCP = 20 Hz, 4 C, 2p), 135.35 (d, 
1JCP = 10 Hz, 2 C, 1p), 145.10 (d, 
1JCP = 17 Hz, 1 H, 1b). 
31P{1H} NMR (CDCl3): δ −3.7 (s). IR (Nujol, cm
−1): 2223 m, 1659 w, 1593 m, 1570 w, 1546 
w, 1488 m, 1396 w, 1311 m, 1273 m, 1202 w, 1180 w, 1157 w, 1087 w, 1020 w, 1026 w, 999 
w, 977 w, 955 w, 923 w, 859 w, 825 m, 757 m, 747 m,  666 w, 576 w, 549 m, 502 m, 490 m, 





13C{1H} NMR signals were assigned according to the literature.61 
 
Synthesis of [(μ-Cl)3(μ3-Cl)Cu4(Lo-κP){μ(P,N)-Lo}2] (1) 
 
CuCl + Lo   
                               
→            [Cu4Cl4(Lo)3] 
 
Solution of Lo (57.5 mg, 0.20 mmol) in dichloromethane (8 mL) was added to a suspension of 
copper(I) chloride (19.8 mg, 0.20 mmol) in the same solvent (2 mL). The resulting colorless 
mixture was stirred for 1.5 h. Following evaporation, the solid residue was dissolved in 
a small amount of ethyl acetate and dichloromethane (1:1). The solution was filtered (PTFE 
syringe filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase 
diffusion over several days gave colorless crystals of 1. Yield: 46 mg (73 %). 
 
Characterization: 1H NMR (CDCl3): δ 7.16-7.22 (m, 1 H), 7.32-7.58 (m, 12 H), 7.62-7.67 (m, 
1 H). 31P{1H} NMR (CDCl3): δ −3.7 (br s). IR (Nujol, cm
−1): 3052 m, 2725 w, 2235 m, 1583 
w, 1313 m, 1287 w, 1263 m, 1196 w, 1168 w, 1160 w, 1129 w, 1095 s, 1067 w, 1027 m, 998 
m, 885 w, 846 w, 759 s, 748 s, 735 s, 697 s, 672 w, 582 m, 556 w, 533 m, 502 s, 482 m, 438 
w. ESI+ MS: m/z  450.0 ([Cu2(Lo)Cl]). 637.1 ([Cu(Lo)2]
+). Anal. Calcd for C57H42N3Cl4Cu4P3 




Synthesis of [(μ-Br)2(μ3-Br)2Cu4(Lo-κP)2{μ(P,N)-Lo}2] (2) 
 
CuBr·SMe2 + Lo  
                               
→           [Cu4Br4(Lo)4] 
 
Solution of Lo (57.5 mg, 0.2 mmol) in dichloromethane (6 mL) was added to a suspension 
of copper(I) bromide-dimethyl sulfide complex  (41.1 mg, 0.2 mmol) in the same solvent 
(4 mL). The resulting yellow mixture was stirred for 1.5 h. After evaporation under vacuum, 
the solid crude product was dissolved in a small amount of 1,2-dichloroethane, the solution 
was filtered (PTFE syringe filter, 45 µm pore size) and layered with hexane. Crystallization 
by liquid-phase diffusion over several days provided yellow crystals of 2. Yield: 74 mg 
(86%). 
 
Characterization: 1H NMR (CDCl3): δ 7.20-7.26 (m, 1 H), 7.32-7.39 (m, 4 H), 7.41-7.52 (m, 
4 H), 7.54-7.61 (m, 4 H), 7.67-7.72 (m, 1 H). 31P{1H} NMR (CDCl3): δ −4.8 (br s). IR (Nujol, 
cm−1): 2229 w, 1668 w, 1561 w, 1309 w, 1182 w, 1098 m, 1027 w, 1018 w, 999 w, 829 m, 
749 m, 695 s, 660 w, 619 w, 597 w, 552.6 m, 512 m, 495 w, 484 w, 412 w. ESI+ MS: m/z 
637.1 ([Cu(Lo)2]
+). Anal. Calcd for C76H56N4Br4Cu4P4 (1722.9): C 52.98, H 3.28, N 3.25%. 
Found: C 52.86, H 3.31, N 3.21%. 
 
Synthesis of [(μ3-I)Cu(μ-I)2Cu2{μ(P,N)-Lo}2]n (3) 
 
CuI + Lo   
                               
→            [CuI(Lo)·CuI·CuI(Lo)]n 
 
Solution of Lo (57.5 mg, 0.20 mmol) in dichloromethane (7 mL) was added to a suspension of 
copper(I) iodide  (38.09 mg, 0.2 mmol) in the same solvent (3 mL). The resulting yellow 
mixture was stirred for 2 h. The solid residue obtained after evaporation was dissolved in a 
small amount of chloroform, the solution was filtered (PTFE syringe filter, 45 µm pore size) 
and layered with hexane. Crystallization by liquid-phase diffusion gave yellow-white crystals 
of 3·2CHCl3. Crystals were isolated by suction and dried under vacuum. Yield of 3·CHCl3: 
59 mg (54%). 
 
Characterization: 1H NMR (CDCl3): δ 7.32-7.36 (m, 5 H, PPh2), 7.41-7.46 (m, 5 H, PPh2), 
7.48-7.52 (m, 4 H, C6H4). IR (Nujol, cm
−1): 3056 w, 2226 m, 1582 w, 1307 w, 1192 w, 1165 
59 
 
w, 1096 m, 1027 w, 996 w, 767 m, 756 s, 744 m, 725 w, 693 m, 578 w, 526 m, 501 s, 480 w, 
435 w. ESI+ MS: m/z 499.9 ([Cu(Lo)INa]+), 637.1 ([Cu(Lo)2]
+). Anal. Calcd for 
C38H28N2Cu3I3P2·CHCl3 (1265.3): C 37.02, H 2.31, N 2.21%. Found: C 36.93, H 2.36, N 
2.18%. 
 
Synthesis of [CuCl(Lo-κP)2] (4a) 
 
CuCl + 2 Lo  
                               
→           [CuCl(Lo)2] 
 
Solution of Lo (40.2 mg, 0.14 mmol) in dichloromethane (5 mL) was added to a suspension of 
copper(I) chloride (6.9 mg, 0.07 mmol) in the same solvent (2 mL). The resulting colorless 
mixture was stirred for 1.5 h. and evaporated under vacuum. The solid residue was dissolved 
in a small amount of ethyl acetate, the solution was filtered (PTFE syringe filter, 45 µm pore 
size) and layered with hexane. Crystallization by liquid-phase diffusion over several days 
furnished colorless crystals of 4a. Yield: 35 mg (74 %). 
 
Characterization: 1H NMR (CDCl3): δ 7.29-7.36 (m, 5 H), 7.39-7.44 (m, 3 H), 7.47-7.58 (m, 
6 H). 31P{1H} NMR (CDCl3): δ −3.6 (br s). IR (Nujol, cm
−1): 3054 m, 2679 w, 2222 m, 1964 
w, 1736 w, 1661 w, 1586 w, 1572 w, 1315 w, 1281 w, 1191 w, 1157 w, 1124 m, 1098 s, 1028 
w, 997 m, 965 w, 889 w, 850 w, 773 s, 751 s, 697 s, 618 w, 578 w, 525 s, 505 s, 496 m, 474 
w, 442 w, 424 w, 408 w. ESI+ MS: m/z 637.1 ([Cu(Lo)2]
+), 737.0 ([Cu2(Lo)2Cl]). Anal. Calcd 
for C38H28N2ClCuP2 (673.6): C 67.76, H 4.19, N 4.16 %. Found: C 67.33, H 4.36, N 3.89 %. 
 
Synthesis of [CuBr(Lo-κP)2] (4b) 
 
 
CuBr·SMe2 + 2 Lo   
                               
→           [CuBr(Lo)2] + [Cu4Br4(Lo)4] 
 
Solution of Lo (40.2 mg, 0.14 mmol) in dichloromethane (8 mL) was added to a suspension of 
copper(I) bromide-dimethyl sulfide complex  (14.4 mg, 0.07 mmol) in the same solvent 
(4 mL) and the colorless reaction mixture was stirred for 2 h. After evaporation, the crude 
product was dissolved in a small amount of ethyl acetate, the solution was filtered (PTFE 
syringe filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase 
diffusion over several days afforded white crystals of 4b and yellow of 2. The crystals were 
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isolated by suction, dried under vacuum and separated under a microscope. 
Yield of 4b·1/50AcOEt: 38 mg (75%). Yield of 2·1/50AcOEt: 4 mg (13%). 
 
Characterization data for 2·1/50AcOEt: Anal. Calcd C19H14NBrCuP·1/50AcOEt (436.2): C 
63.15, H 3.98, N 3.87%. Found: C 62.85, H 3.84, N 3.53%. 
 
Characterization data for 4b·1/50AcOEt: 1H NMR (CDCl3): δ 7.25-7.34 (m, 5 H), 7.39-7.44 
(m, 5 H), 7.48-7.58 (m, 4 H). 31P{1H} NMR (CDCl3): δ −3.7 (br s). IR (Nujol, cm
−1): 3051 w, 
2223 m, 1572 w, 1583 w, 13115 m, 1280 m, 1266 w, 1097 s, 1072 w, 1026 m, 997 m, 969 w, 
931 w, 885 w, 845 w, 763 s, 756 m, 744 m, 726 m, 670 m, 672 w, 619 w, 578 m, 527 s, 503 s, 
474 m, 433 w, 410 m. ESI+ MS: m/z 637.1 ([Cu(Lo)]+). Anal. Calcd for compound 4b:  
C38H28CuN2P2Br·1/50AcOEt (723.4): C 52.43, H 3.26, N 3.21%. Found: C 52.41, H 3.28, N 
2.39%. 
 
Synthesis of [CuI(Lo-κP)2] (4c) 
 
 
CuI + 2 Lo   
                               
→           [CuI(Lo)2]  
 
Solution of Lo (46.0 mg, 0.16 mmol) in dichloromethane (6 mL) was added into a suspension 
of copper(I) iodide  (15.2 mg, 0.08 mmol) in the same solvent (2 mL) and the obtained 
colorless mixture was stirred for 2 h and then evaporated. The solid residue was dissolved in a 
small amount of chloroform, the solution was filtered (PTFE syringe filter, 45 µm pore size) 
and layered with hexane. Crystallization by liquid-phase diffusion over several days afforded 
colorless crystals of 4c. Yield: 51 mg (83%). 
 
Characterization: 1H NMR (CDCl3): δ 7.31-7.36 (m, 5 H), 7.40-7.46 (m, 5 H), 7.48-7.61 (m, 
4 H). 31P{1H} NMR (CDCl3): δ −4.9 (br s). IR (Nujol, cm
−1): 3056 w, 2676 w, 2225 m, 1835 
w, 1581 w, 1306 w, 1279 w, 1266 w, 1164 w, 1095 m, 1072 w, 1026 w, 1004 w, 995 w, 882 
w, 766 m, 756 s, 725 m, 707 m, 699 s, 690 m, 673 w, 619 w, 579 w, 555 w, 526 s, 501 s, 481 
m, 434 w, 411 w. ESI+ MS: m/z 637.0 ([Cu(Lo)2]
+). Anal. Calcd for C38H28N2CuIP2 (765.0): 





Synthesis of [{μ(P,N)-Lo}Cu(μ-Cl)]n (5a) 
 
CuCl + Lp 
                               
→            [CuCl(Lp)]n   
 
Solution of Lp (57.5 mg, 0.20 mmol) in dichloromethane (8 mL) was added to a suspension 
of copper(I) chloride (19.8 mg, 0.20 mmol) in the same solvent (2 mL). The resulting 
colorless mixture was stirred for 1.5 h and evaporated, leaning a solid residue, which was 
immediately dissolved in a small amount of chloroform. The solution was filtered (PTFE 
syringe filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase 
diffusion furnished yellow crystals of 5a·2CHCl3. The crystals were isolated by suction and 
dried under vacuum. Yield of 5a·1/20CHCl3: 50 mg (56%). 
 
Characterization: 1H NMR (CDCl3): δ 7.27-7.33 (m, 4 H), 7.39-7.57 (m, 10 H). IR (Nujol, 
cm−1): 3045 m, 2726 w, 2234 m, 1671 w, 1593 s, 1310 m, 1007 w, 1182 m, 1158 w, 1096 s, 
1070 w, 1027 m, 1019 m, 998 w, 969 w, 920 w, 831 s, 756 s, 744 s, 718 m, 696 s, 619 w, 592 
m, 554 s, 511 s, 495 m, 432 w, 410 w. ESI+ MS: m/z 637.1 ([Cu(Lp)2]
+), 737.0 
([Cu2(Lp)2Cl]
+). Anal. Calcd for C19H14NClCuP·1/20CH2Cl2 (390.5): C 58.33, H 3.61, 
N 3.57%. Found: C 58.21, H 3.54, N 3.33%. 
 
Synthesis of [{μ(P,N)-Lo}Cu(μ-Br)]n and [(μ3-Br)4{Cu(Lo-κP)}4] (5b and 6b) 
 
CuBr + Lp 
                               
→            [CuBr(Lp)]n + [CuBr(Lp)]4 
       
Solution of Lp (57.5 mg, 0.2 mmol) in dichloromethane (5 mL) was added to a suspension of 
copper(I) bromide-dimethyl sulfide complex  (41.1 mg, 0.2 mmol) in the same solvent 
(3 mL). The yellow mixture was stirred for 1 h and evaporated under vacuum. The solid 
residue was dissolved in a small amount of dichloromethane, the solution was filtered (PTFE 
syringe filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase 
diffusion over several days afforded yellow crystals of 5b·0.5CH2Cl2 and white crystals 
of 6b·CH2Cl2 (3 mg, yield 3%). The crystals were isolated by suction and dried under 





Characterization for 5b·1/3CH2Cl2: 
1H NMR (CDCl3): δ 7.27-7.34 (m, 4 H), 7.41-7.57 (m, 10 
H). 31P{1H} NMR (CDCl3): δ –8.5 (br s). IR (Nujol, cm
−1): 2241 w, 2230 m, 1589 m, 1308 w, 
1180 w, 1158 w, 1098 s, 1071 w, 1027 w, 1017 w, 999 w, 972 w, 824 s, 748 s, 695 s, 643 w, 




+). Anal. Calcd for C19H14NBrCuP·1/3CH2Cl2 
(459.0): C 50.58, H 3.22, N 3.05%. Found: C 50.33, H 3.19, N 2.75%. 
 
Synthesis of [(μ3-I)4{Cu(Lo-κP)}4] (6c) 
 
CuI + Lp 
                               
→            [CuI(Lp)]4 
 
Solution of Lp (19.0 mg, 0.10 mmol) in dichloromethane (6 mL) was added 
to a dichloromethane suspension of copper(I) iodide  (28.7 mg, 0.10 mmol, in 2 ml). 
The yellow reaction mixture was stirred for 2 h and evaporated. The solid residue was 
dissolved in a small amount of ethyl acetate, the solution was filtered (PTFE syringe filter, 
45 µm pore size) and layered with hexane. Crystallization by liquid-phase diffusion afforded 
yellow crystals of 6c. Yield: 24 mg (50%). 
 
Characterization: 1H NMR (CDCl3): δ 7.31-7.37 (m, 4 H), 7.46-7.58 (m, 10 H). 
31P{1H} 
NMR (CDCl3): δ −20.7 (br s). IR (Nujol, cm
−1): 3075 w, 3059 w, 2678 w, 2223 s, 1972 w, 
1923 w, 1812 w, 1739 m, 1663 w, 1593 s, 1574 m, 1547 w, 1397 m, 1306 m, 1244 m, 
1203 w, 1178 m, 1157 m, 1097 s, 1069 w, 1047 w, 1031 m, 1015 m, 998 w, 97 w, 958 w, 
918 w, 845 w, 827 s, 753s, 706w, 692 s, 620 w, 585 s, 554 s, 503 s, 488 m, 420 w. ESI+ MS: 
m/z 637.1 ([Cu(Lp)2]
+). Anal. Calcd for C76H56N4Cu4I4P4 (477.73): C 47.77, H 2.95, N 2.93% 
Found: C 48.03, H 3.05, N 2.48%. 
 
Synthesis of [{μ(C,N)-CN}Cu(Lo-κP)]n (7) 
 
CuCN + Lo 
                               
→            [CuCN(Lo)]n 
 
Solution of Lo (71.8 mg, 0.25 mmol) in dichloromethane (7 mL) was added to 
a dichloromethane suspension of copper(I) cyanide  (22.4 mg, 0.25 mmol, in 2 ml) and 
resulting colorless mixture was stirred for 2.5 h and then evaporated. The crude product was 
taken up with a small amount of dichloromethane. The solution was filtered (PTFE syringe 
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filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase diffusion 
over 7 days provided colorless crystals of 7. The crystals were isolated by suction and dried 
under vacuum. Yield of 7·1/10CH2Cl2: 66 mg (68%). 
 
Characterization: NMR (CDCl3): 
1H NMR (CDCl3): δ 7.09-7.14 (m, 1 H), 7.32-7.51 (m, 
12 H), 7.64-7.68 (m, 1 H). 31P{1H} δ −7.0 (s).  IR (Nujol, cm−1): 3049 w, 2674 w, 2227 m, 
2128 s, 1585 w, 1307 w, 1283 w, 1193 w, 1165 w, 1129 w, 1096 m, 1068 w, 1027 w, 999 w, 
919 w, 847 w, 765 s, 752 s, 745 s, 727 w, 707 w, 695 s, 674 w, 581 m, 527 s, 505 s, 494 s, 
478 w, 436 w, 407 w. ESI+ MS: m/z 726.0 ([Cu2CN(Lo)2]
+). Anal. Calcd for 
C20H14N2CuP·1/10CH2Cl2 (385.3): C 62.65, H 3.71, N 7.27 % Found: C 62.72, H 3.64, N 
6.95 %. 
 
Synthesis of [{μ(P,N)-Lo}2{Cu(H2O)(MeCN)}2][BF4]2 (8) 
 
[Cu(MeCN)4][BF4] + Lo 
                               
→            [Cu(MeCN)(H2O)(Lo)]2[BF4]2 
 
Solution of Lo (57.4 mg, 0.20 mmol) in dichloromethane (10 mL) was added to suspension 
of tetrakis(acetonitrile)copper(I) tetrafluoroborate (57.4 mg, 0.20 mmol) in the same solvent 
(5 mL). After stirring for 6 h, the reaction mixture was evaporated, yields a residue which was 
dissolved in small amount of ethyl acetate. The solution was filtered (PTFE syringe filter, 
45 µm pore size) and layered with hexane. Crystallization by liquid-phase diffusion gave 
colorless crystals of 8. Yield: 59.0 mg (62 %). 
 
Characterization: 1H NMR (CD3COCD3): δ 2.21 (s, 3 H, MeCN), 3.10 (br s, 2 H, H2O), 7.08-
7.16 (m, 1 H), 7.44-7.68 (m, 10 H), 7.80-7.90 (m, 2 H), 8.18-8.26 (m, 1 H). 31P{1H} NMR 
(CD3COCD3): δ −0.91 (br s). IR (Nujol, cm
−1): 3049 w, 2308 w, 2278 w, 1840 w, 1630 br m, 
1586 w, 1308 w, 1284 w, 1194 m, 11302 m, 1097 s, 1068 s, 1068 s, 1034 s, 1023 s, 998 s, 
961 m, 885 w, 788 w, 770 s, 754 s, 445 s. 708 m, 694 s, 673 w, 580 m, 540s, 513 m, 499 s, 
436 w. ESI+ MS: m/z 637.0 ([Cu(Lo)2]
+). Anal. Calcd for C42H38N4B2Cu2F8O2P2 (993.4): 





Synthesis of [{μ(P,N)-Lo}2Cu]3[BF4]3 (9) 
 
 
[Cu(MeCN)4][BF4] + 2 Lo 
                               
→            [Cu3(Lo)6][BF4]3 
 
Solution of Lo (57.4 mg, 0.20 mmol) in dichloromethane (4 mL) was added to a suspension of 
tetrakis(acetonitrile)copper(I) tetrafluoroborate  (31.5 mg, 0.1 mmol) in the same solvent 
(3 mL). The resulting mixture was stirred for 2 h. The solid residue obtained after evaporation 
was dissolved in a small amount of dichloromethane, the solution was filtered (PTFE syringe 
filter, 45 µm pore size) and layered with hexane. Crystallization by liquid-phase diffusion 
gave white crystals of 9·CH2Cl2. Yield: 54 mg (72%). 
 
Characterization: 1H NMR (CD2Cl2): δ 6.02-6.042 (m, 1 H), 6.52-6.60 (m, 2H), 6.95-7.78 (m, 
23 H), 7.80-781 (m, 1 H), 8.02-8.07 (m, 1 H). 31P{1H} NMR (CD2Cl2): δ −2.0 (s) and −3.3 
(br s). ESI+ MS: m/z 637.0 ([Cu(Lo)2]
+). IR (Nujol, cm−1): 2236 w, 1653 w, 1580 w, 1481 w, 
1436 s, 1312 w, 1286 w, 1197 w, 1160 w, 1092 s, s 1059 s, 1000 m, 765 m, 752 m, 744 m, 
723 w, 698s.  Anal. Calcd for C114H84N6B3Cu3F12P6·CH2Cl2 (2259.7): C 61.12, H 3.84, N 
3.72% Found: C 61.48, H 3.92, N 3.65%.    
 
Synthesis of [{μ(P,N)-Lo}2{Cu(MeO-Lo-κP)}2][BF4]2 (10) 
 
[Cu(MeCN)4][BF4] + 2 Lo 
                               
→            [Cu(Lo)(MeO-Lo)]2[BF4]2 
 
Solution of Lo (86.2 mg, 0.30 mmol) in dichloromethane (2 mL) was added to a suspension 
of tetrakis(acetonitrile)copper(I) tetrafluoroborate  (47.2 mg, 0.15 mmol) in the methanol 
(4 mL). The resulting mixture was refluxed in argon atmosphere for 6 h. The solid residue 
obtained after evaporation was dissolved in a small amount of chloroform, the solution was 
filtered (PTFE syringe filter, 45 µm pore size) and layered with hexane. Crystallization by 
liquid-phase diffusion gave white crystals of 10·6CHCl3. The crystals were isolated by 




Characterization: ESI+ MS: m/z 382.0 ([Cu(MeO-Lo)]+), 637.0 ([Cu(Lo)2]
+), 669.0 
([Cu(Lo)(MeO-Lo)]+). 701.0 ([Cu(MeO-Lo)2]
+). IR (Nujol, cm−1):  3288 m, 2238 w, 1643 m, 
1585 w, 1559 w, 1541 w, 1309 w, 1287 w, 1202 w, 1187 w, 1164 w, 1134 w, 1114 w, 1066 s, 
1030 m, 997 w, 805 w, 777 w, 748 w, 724 w, 698 m, 669 w, 579 w, 501 m, 482 w, 430 w, 
412 w. Anal. Calcd for C78H64N4B4Cu4F8O2P4 (1513.9): C 61.88, H 4.26, N 3.70% Found: 







5.1 Crystallographic data 
 
Crystallographic data, data collection and structure refinement parameters for prepared 




Table 5.1: Crystallographic data, data collection and structure refinement parameters for Lp, 1, 2 and 3. 
 
Compound Lp 1 2 3·2CHCl3 
Formula C19H14NP C57H42Cl4Cu4N3P3 C76H56Br4Cu4N4P4 C38H28Cu3I3N2P2·2 CHCl3 
M [g/mol] 287.28 1257.81 1722.93 1503.99 
Crystal system monoclinic triclinic triclinic monoclinic 
Space group P21/n (no. 14) P-1 (no. 2) P-1 (no. 2) C2/c (no. 15) 
a [Å] 9.6939(2) 11.3832(2) 10.5092(3) 19.2696(5) 
b [Å] 15.7842(4) 15.4185(3) 11.7864(3) 16.1991(3) 
c [Å] 10.7560(2) 19.9852(4) 14.8827(4) 17.8699(4) 
α [°]  86.781(1) 87.923(1)  
β [°] 115.743(1) 88.440(1) 74.051 (1) 114.522(1) 
γ [°]  89.396(1) 78.127(1) 114.522(1) 
V [Å3] 1482.44(6) 3500.66(12) 1734.17(8) 5075.0(2) 
Z 4 2 1 4 
Dcalc [g/cm
3] 1.287 1.193 1.650 1.968 
F(000) 312 1268 856 2880 
Collected diffractions 13940 53526 22770 18641 
Rint [%]
a 2.60 2.48 2.29 3.80 
Independent diffractions   2890 16054 7976 5829 
Observed diffractions 2657 12732 6724 4508 
R (observed diffractions) [%]c 3.11 3.08 2.39 3.38 
R (all diffractions) [%]c 3.39 4.05 3.30 5.03 
wR (all diffractions) [%]d 8.12 7.94 5.61 8.18 






Table 5.2: Crystallographic data, data collection and structure refinement parameters for 4a-c and 5a. 
 
Compound 4a 4b 4c 5a·2CHCl3 
Formula C38H28ClCuN2P2 C38H28BrCuN2P2 C38H28CuIN2P2 C19H14ClCuNP·2CHCl3 
M [g/mol] 673.55 718.01 765.00 625.01 
Crystal system monoclinic triclinic monoclinic monoclinic 
Space group C2/c (no. 15) P-1 (no. 2) C2/c (no. 15) P21/n (no. 14) 
a [Å] 20.4046(5) 9.9490(2) 19.0763(3) 13.1063(3) 
b [Å] 10.0455(2) 10.4805(2) 9.8794(2) 10.2714(3) 
c [Å] 17.0571(4) 17.6769(4) 19.684(3) 20.1935(5) 
α [°]  81.782(1)   
β [°] 109.185(9) 78.027(1) 117.686(7) 98.921(1) 
γ [°]  65.535(1)   
V [Å3] 3302.09(13) 1637.82(6) 3284.87(10) 2685.50(12) 
Z 4 2 4 4 
Dcalc [g/cm
3] 1.355 1.456 1.547 1.546 
F(000) 1384 728 1528 1248 
Collected diffractions 20888 24906 10518 17292 
Rint [%]
a 4.28 2.05 1.71 2.40 
Independent diffractions   3797 7516 3595 5279 
Observed diffractions 3073 6480 3234 4088 
R (observed diffractions) [%]c 3.16 2.82 2.24 5.06 
R (all diffractions) [%]c 4.52 3.56 2.62 6.71 
wR (all diffractions) [%]d 6.77 6.47 5.65 13.8 






Table 5.3: Crystallographic data, data collection and structure refinement parameters for 5b, 6b-c and 7. 
 
Compound 2 (5b)·CH2Cl2 6b·CH2Cl2  6c 7 
Formula 2 (C19H14BrCuNP) · CH2Cl2 C76H56Br4Cu4N4 · CH2Cl2 C76H56Cu4I4 N4P4 C20H14CuN2P 
M [g/mol] 946.39 1807.85 1910.89 376.84 
Crystal system triclinic orthorhombic tetragonal monoclinic 
Space group P-1 (no. 2) C2221 (no. 20) I41/a (no. 88) P21/c (no. 14) 
a [Å] 10.2501(2) 15.0323(7) 21.8593(6) 10.6218(2) 
b [Å] 11.5577(2) 19.5583(9) 21.8593(6) 18.8904(3) 
c [Å] 17.3967(3) 25.1167(12) 14.9540(4) 8.9534(2) 
α [°] 105.894(1)    
β [°] 96.247(1)   105.896(1) 
γ [°] 98.958(1)    
V [Å3] 1932.94(6) 7384.5(6) 7145.5(3) 1727.81(6) 
Z 2 4 4 4 
Dcalc [g/cm
3] 1.626 1.626 1.776 1.449 
F(000) 940 3592 3712 768 
Collected diffractions 29574 26444 20110 13483 
Rint [%]
a 3.05 5.23 3.58 1.80 
Independent diffractions   8874 7174 4101 3961 
Observed diffractions 6701 6486 3379 3538 
R (observed diffractions) [%]c 3.74 4.29 2.69 2.49 
R (all diffractions) [%]c 5.65 4.92 3.77 2.95 
wR (all diffractions) [%]d 10.5 9.19 6.35 6.49 






Table 5.4: Crystallographic data, data collection and structure refinement parameters for 8, 9 and 10. 
 
Compound 8 9·CH2Cl2 10·6CHCl3 
Formula C42H38B2Cu2F8N4O2P2 C114H83B3Cu3F12N6P6 · CH2Cl2 C78H64B2Cu2F8N4 O2P4 · 6 CHCl3 
M [g/mol] 993.40 2258.65 2230.12 
Crystal system monoclinic monoclinic triclinic 
Space group P21/c (no. 14) Cc (no. 9) P-1 (no. 2) 
a [Å] 12.5469(2) 25.1774(7) 13.8949(5) 
b [Å] 9.2121(2) 23.5784(6) 14.8300(6) 
c [Å] 19.7221(4) 19.5647(5) 14.9456(6) 
α [°]   118.749(1) 
β [°] 101.253(1) 101.043(1) 98.180(1) 
γ [°]   108.171(2) 
V [Å3] 2235.72(8) 11399.4(5) 2402.3(2) 
Z 2 4 1 
Dcalc [g/cm
3] 1.476 1.316 1.541 
F(000) 1008 4604 1124 
Collected diffractions 19081 77193 67891 
Rint [%]
a 1.72 3.56 2.26 
Independent diffractions   5123 22403 11054 
Observed diffractions 4578 20852 9313 
R (observed diffractions) [%]c 2.70 3.95 3.62 
R (all diffractions) [%]c 3.15 4.37 5.66 
wR (all diffractions) [%]d 7.32 10.7 8.95 









b 𝐼𝑜 ≥ 2𝜎(𝐼𝑜)   
c R = (|𝐹𝑜| − |𝐹𝑐|)/ ∑|𝐹𝑜| 







 , where 𝑤 = [𝜎2𝐹𝑜
2 + (𝑤1𝑃)
2 + 𝑤2𝑃]
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